“…Hence, before CQ and HCQ treatment, an initial cardiac evaluation is necessary for COVID-19 patients ( Zhou W. et al, 2020 ). Also, several follow-up evaluations, such as regular ophthalmological examination and cardiac monitor, are suggested for patients with short- or long-term treatment ( Knox and Owens, 1966 ). Thus, using CQ or HCQ as a COVID-19 treatment was controversial, which results from their ocular, cardiac, and neuro toxicities ( Oren et al, 2020 ; Zou et al, 2020 ).…”